Back to News

BioEurope Spring – virtual

GenSight will participate to the BioEurope Spring, a virtual conference held from March 22 to 25, 2021, and will host partnering meetings.

Back to News

A New Chapter

Founded in 2012 to realize the potential of gene therapy, GenSight Biologics has grown into a clinical-stage company advancing multiple programs. In 2024, under a new management team, the company entered a new phase and is now accelerating its clinical and regulatory activities.

Explore investors’ hub

GenSight Biologics S.A.
74 rue du Faubourg Saint-Antoine
75012 Paris
France